Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders
128 employees · est. 2018 · La Jolla, United States
Garuda Therapeutics
Creating off-the-shelf, long-term durable blood stem cell therapies
9 employees · est. 2021 · Cambridge, United States
Aspen Neuroscience, Inc. is the older company (2018 vs 2021); Aspen Neuroscience, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Aspen Neuroscience, Inc. | Garuda Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2021 |
| Headquarters | ||
| Headquarters | La Jolla, United States | Cambridge, United States |
| Employees | ||
| Employees | 128 larger | 9 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Series B |
| Total Funding | ||
| Total Funding | $387.00M | $134.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 2 |
| Services | ||
| Services | Development of autologous cell therapies, Clinical trial management, Manufacturing scalable cell therapies, Research in stem cell biology and genomics | Domain name sales, Domain name leasing, Secure online transactions, Domain transfer services |
| Target Customers | ||
| Target Customers | Patients with Parkinson's disease, Healthcare providers specializing in neurology, Clinical trial participants | Businesses seeking premium domain names, Individuals or companies interested in digital real estate, Digital marketers and branding agencies |
| Taxonomy | ||
| Taxonomy | Autologous Cell Therapy, IPSC-Derived Therapies, Parkinson's Disease Treatment, Neuroscience, Regenerative Medicine, Induced Pluripotent Stem Cells, Genomics, Stem Cell Biology, Machine Learning In Biotech, Bioinformatics, Cell Replacement Therapy, CNS Disorders, Private Biotechnology, Patient-Specific Therapies, Development Stage Biotech | Off-the-shelf Therapies, Stem Cell Therapy, Hematopoietic Stem Cells, Transgene-free Therapies, HLA-compatible Cells, Biotech Startup, Blood Stem Cell Transplants, Curative Therapies, Pluripotent Stem Cells, Oncology Treatments, Hematologic Malignancies, Sickle Cell Disease Solutions, Beta Thalassemia Treatments, Bone Marrow Failure, Cell Therapy Manufacturing |
| Website | ||
| Website | aspenneuroscience.com | garudatx.com |
About Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc., founded in 2018, is at the forefront of developing autologous iPSC-derived cell replacement therapies targeting Parkinson’s disease and other CNS disorders. Under the slogan "Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS...
About Garuda Therapeutics
Garuda Therapeutics, founded in 2021, is a rapidly evolving company in the Biotechnology and Life Sciences sectors. Headquartered in the United States, the company focuses on developing "off-the-shelf, long-term durable blood stem cell therapies" to eliminate reliance on donor or patient cells for b...
We will tell you when either one moves
BounceWatch watches Aspen Neuroscience, Inc. and Garuda Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aspen Neuroscience, In... and Garuda Therapeutics — by email.
Frequently Asked Questions
Compare Aspen Neuroscience, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Aspen Neuroscience, Inc. on 9 Jun 2026, and Garuda Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
